The Use of Fibrin-based Tissue Adhesives for Breast in Reconstructive and Plastic Surgery.


Journal

Current topics in medicinal chemistry
ISSN: 1873-4294
Titre abrégé: Curr Top Med Chem
Pays: United Arab Emirates
ID NLM: 101119673

Informations de publication

Date de publication:
2019
Historique:
received: 06 09 2019
revised: 02 10 2019
accepted: 10 10 2019
pubmed: 14 11 2019
medline: 18 2 2020
entrez: 14 11 2019
Statut: ppublish

Résumé

Breast plastic surgery is a rapidly evolving field of medicine. The modern view of surgical trends reflects the desire to minimize complications and introduce advanced technologies. These always will be priorities for surgeons. Reconstructive surgery, a branch of plastic surgery focusing on restoration of lost functional and aesthetic component, seeks to enhance psychological rehabilitation and improves the quality of life, as well as aesthetic recovery. This review addresses the action of fibrin agents and their effect on the quality of surgical hemostasis. The fundamental goals for the surgeon are to perform a minimally traumatic intervention and to prevent any form of complication. Achieving complete hemostasis is an intraoperative necessity. Timely prevention of bleeding and hemorrhagic phenomena can affect not only the outcome of the operation, but also the incidence of postoperative complications. Topics include the integrity of microvascular anastomoses, tissue adhesion, and the incidence of seromas and hematomas associated with fibrin glue usage. The literature on fibrin adhesives with respect to prevention of postoperative complications, and the effectiveness with active drainage also are analyzed.

Sections du résumé

BACKGROUND BACKGROUND
Breast plastic surgery is a rapidly evolving field of medicine. The modern view of surgical trends reflects the desire to minimize complications and introduce advanced technologies. These always will be priorities for surgeons. Reconstructive surgery, a branch of plastic surgery focusing on restoration of lost functional and aesthetic component, seeks to enhance psychological rehabilitation and improves the quality of life, as well as aesthetic recovery.
OBJECTIVE OBJECTIVE
This review addresses the action of fibrin agents and their effect on the quality of surgical hemostasis.
DISCUSSION AND CONCLUSION CONCLUSIONS
The fundamental goals for the surgeon are to perform a minimally traumatic intervention and to prevent any form of complication. Achieving complete hemostasis is an intraoperative necessity. Timely prevention of bleeding and hemorrhagic phenomena can affect not only the outcome of the operation, but also the incidence of postoperative complications. Topics include the integrity of microvascular anastomoses, tissue adhesion, and the incidence of seromas and hematomas associated with fibrin glue usage. The literature on fibrin adhesives with respect to prevention of postoperative complications, and the effectiveness with active drainage also are analyzed.

Identifiants

pubmed: 31721704
pii: CTMC-EPUB-102255
doi: 10.2174/1568026619666191112101448
doi:

Substances chimiques

Fibrin Tissue Adhesive 0
Hemostatics 0

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

2985-2990

Informations de copyright

Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.

Auteurs

Kuo Chen (K)

I.M. Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation (Sechenov University), 8/2 Trubetskaya str., Moscow 119991,Russian Federation.

Mikhail Y Sinelnikov (MY)

I.M. Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation (Sechenov University), 8/2 Trubetskaya str., Moscow 119991,Russian Federation.

Vladimir N Nikolenko (VN)

I.M. Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation (Sechenov University), 8/2 Trubetskaya str., Moscow 119991,Russian Federation.
Department of Normal and Topographic Anatomy, Faculty of Fundamental Medicine, M.V. Lomonosov Moscow State University (MSU), 31-5 Lomonosovsky Prospekt, 117192 Moscow, Russian Federation.

Igor V Reshetov (IV)

I.M. Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation (Sechenov University), 8/2 Trubetskaya str., Moscow 119991,Russian Federation.

Yu Cao (Y)

I.M. Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation (Sechenov University), 8/2 Trubetskaya str., Moscow 119991,Russian Federation.

Zhi Li (Z)

I.M. Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation (Sechenov University), 8/2 Trubetskaya str., Moscow 119991,Russian Federation.

Ekaterina V Kochurova (EV)

I.M. Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation (Sechenov University), 8/2 Trubetskaya str., Moscow 119991,Russian Federation.

Svetlana N Nikolenko (SN)

I.M. Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation (Sechenov University), 8/2 Trubetskaya str., Moscow 119991,Russian Federation.

Marco Avila-Rodríguez (M)

Department of Clinical Sciences, Faculty of Health Sciences, University of Tolima, Ibagué -730001,Colombia.

Siva G Somasundaram (SG)

Department of Biological Sciences, Salem University, 223 West Main Street Salem, WV 26426,United States.

Cecil E Kirkland (CE)

Department of Biological Sciences, Salem University, 223 West Main Street Salem, WV 26426,United States.

Gjumrakch Aliev (G)

I.M. Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation (Sechenov University), 8/2 Trubetskaya str., Moscow 119991,Russian Federation.
Institute of Physiologically Active Compounds, Russian Academy of Sciences, Chernogolovka 142432, Russian Federation.
GALLY International Research Institute, 7733 Louis Pasteur Drive, #330, San Antonio, TX 78229, United States.
Research Institute of Human Morphology, 3 Tsyurupy Street, Moscow, 117418, Russian Federation.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH